The largest database of trusted experimental protocols

131 protocols using orlistat

1

Cytotoxicity Evaluation of Orlistat and Rosuvastatin

Check if the same lab product or an alternative is used in the 5 most similar protocols
K562 cells were divided into five groups and treated with 0 µM, 20 µM, 40 µM, 60 µM, and 80 µM of Orlistat (Sigma) and Rosuvastatin (Sigma) or with a mixture of Orlistat and Rosuvastatin for 24 h, 48 h, and 72 h. After IC50 analyzing, for downstream measurements, cells were co-cultured with Orlistat and Rosuvastatin over a period of 72 h. Compounds were dissolved in 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (DMSO, Merck) solution.
+ Open protocol
+ Expand
2

Inhibition of FASN in Colorectal Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the application of the FASN synthetase inhibitor Orlistat (O4139-25MG, Merck, Darmstadt, Germany) in vitro, the inhibitor was prepared by referencing the procedure of Browne et al. [17 (link)], and 200 µmol/L Orlistat was adopted to treat CRC cells for 48 h when necessary. Another FASN inhibitor, C75 (25–200 µmol/L) (HY-12364, MedChemExpress, Monmouth Junction, NJ, USA), was used to treat CRC cells for 48 h as per a report from Chen et al. [11 (link)]. Based on a previous study [18 (link)], 800 µmol/L of palmitoleic acid (HY-N1966, MedChemExpress) was applied for 72 h for in vitro experiments.
+ Open protocol
+ Expand
3

Inhibition of CRC Cell Growth

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the application of the FA synthetase inhibitor orlistat (O4139‐25MG, Merck, Darmstadt, Germany) in vitro, it was prepared by referencing the procedure of Browne et al. [25 (link)], and 50 μmol/L orlistat was adopted to treat CRC cells for 48 h when necessary. As for in vivo experiments, it was prepared as described by Kridel et al. [26 (link)], and it was intraperitoneally injected into nude mice with a concentration of 240 mg/kg. The phosphoInositide‐3 kinase (PI3K) inhibitor LY294002 (20 μmol/L) (HY‐10108, MedChemExpress, Monmouth Junction, NJ, USA) was used to treat CRC cells for 24 h as per a report from Chen et al. [27 (link)]. Based on a previous study [28 (link)], 40 μmol/L mitogen‐activated protein kinase (MAPK) inhibitor (E)‐osmundacetone (HY‐N1966, MedChemExpres) was applied for 24 h for in vitro experiments.
+ Open protocol
+ Expand
4

Cytotoxic Effects of Orlistat on HEK293T/17 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytotoxicity of orlistat (Merck KGaA) was evaluated in HEK293T/17 cells at 36 h with pre-, post-, or pre- and post-combined treatments using a Trypan Blue viability testing protocol. Dilutions of cell suspensions were mixed 1:1 with 0.4% Trypan Blue prior to counting live cells using a hemocytometer under a microscope. Negative controls (only DMEM and vehicle DMSO control of each concentration) and positive controls (milli-Q water) were undertaken in parallel. In addition, cell morphology was evaluated under an inverted light microscope.
+ Open protocol
+ Expand
5

Preparation of Baicalein and Orlistat Solutions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Baicalein (Supplemental Fig. 1; Merck KGaA, Darmstadt, Germany) was dissolved in 100% DMSO (Merck KGaA, Darmstadt, Germany) to give a stock solution concentration of 100 mM, which was stored at -30 ºC until used. Working solutions were prepared by diluting the stock solution in complete cell culture medium to the desired concentration. Orlistat (Merck KGaA, Darmstadt, Germany) was dissolved in 100% DMSO to give a stock concentration of 38.3 mM and was also stored at -30oC until used.
+ Open protocol
+ Expand
6

Antibody Reagents and Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies used in this study are shown in Supplementary Table 2. The following reagents were purchased from the manufacturers as noted: DMXAA (14617, Cayman), anti-FLAG M2 Affinity Gel (A2220, Sigma), LysoTracker Deep Red (L12492, Thermo Fisher Scientific), E64d (4321, Peptide Institute), pepstatin A (4397, Peptide Institute), orlistat (O4139, MERCK) and HT-DNA (D6898, Sigma).
+ Open protocol
+ Expand
7

Optimizing C. pyrenoidosa Protein Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
C. pyrenoidosa powder (62.4% of total protein contents) was provided by Professor Zhang Daojing, East China University of Technology, Shanghai, China. BCA Protein Assay Kit and Triglyceride Assay Kit were purchased from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). Pepsin (300,000 U/g), papain (800,000 U/g), and trypsin (1:250 U/g) were obtained from Guangzhou Qiyun Biotech Co., Ltd., Guangzhou, China. Alcalase 2.4 L (P4860), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), pancreatic lipase, Orlistat, and simvastatin were obtained from Sigma, San Jose, CA, USA. Primary and secondary antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA). Gel filtration chromatography Sephadex G-25 was from Whatman Liluo Science & Technology Instrument Co., Guangzhou, China. Other reagents were of analytical grade and were commercially available.
+ Open protocol
+ Expand
8

Lipase and Pepsin Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sodium hydroxide (NaOH), hydrochloric acid (HCl), trichloroacetic acid (TCA) and acetic acid were from Fisher Scientific (Dublin, Ireland). Kjeldahl tablets, sulfuric acid (>98%, H2SO4), boric acid, trifluoroacetic acid (TFA), Trizma® base, dimethyl sulfoxide (DMSO), 2-mercaptoethanol, methanol, protein markers (6.5–200 kDa), Sudan III, 2,4,6-trinitrobenzenesulfonic acid (TNBS), 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), porcine pepsin (2500 U/mg), porcine pancreatic lipase (50 mU/mL), 4-methylumbelliferyl oleate (4-MUO) and Orlistat® were from Sigma-Aldrich (Dublin, Ireland). Hexane, MS-grade water and acetonitrile (ACN) were from Honeywell International Inc. (Dublin, Ireland). Comassie R, Laemmli buffer and Mini-Protean TGX 4–20% pre-cast polyacrylamide gels were from Bio-Rad Laboratories Inc. (Hercules, CA, USA). Sodium dodecyl sulfate (SDS) was from National Diagnostics (Atlanta, GA, USA). Corolase PP® (4.4 U/mg) was from AB Enzymes GmbH (Darmstadt, Germany). Cellulose acetate filters were from Millipore (Carrigtwohill, Ireland) and polytetrafluoroethylene syringe filters were from VWR (Dublin, Ireland).
+ Open protocol
+ Expand
9

Antioxidant Capacity Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
1,1-diphenyl-2 picrylhydrazyl (DPPH), 2,2′-Azinobis (3-ethyl benzthiazoline-6-sulphonic acid) liquid substrate (ABTS), trolox, ascorbic acid (AA), hydrogen peroxide (H2O2), Folin-Ciocalteu phenol reagent, nitroblue tetrazolium (NBT), superoxide dismutase (SOD), catalase (CAT), glutathione (GSH), catechin, quercetin, orlistat were obtained from Sigma-Aldrich Chemicals (St Louis, MO, USA). Other chemicals of analytical grade were purchased from Merck Limited (Mumbai, India).
+ Open protocol
+ Expand
10

Orlistat Inhibits Triglyceride Hydrolysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Orlistat (Sigma-Aldrich Co.) was solubilized in 33% ethanol and 66% PEG 400 (Hampton Research, Aliso Viejo, CA, USA). The C57BL/6 mice fed a standard chow diet received Orlistat (250 mg kg−1 body weight) via injection into the intraperitoneal space26 (link), followed 90 min later by measurement of plasma TG-hydrolysis activities. Next, serum TG levels were measured and HPLC analyses of lipid profiles were performed.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!